Mitsui & Co. Global Investment is the corporate venture arm of Mitsui & Co., the Japanese trading and investment group. The firm has been operating for more than 20 years and has invested in over 100 portfolio companies, with more than 35 exits to date through M&A, IPOs and SPAC mergers.
Its showcased portfolio spans biotech and healthcare — Waypoint Bio, which is running CAR-T trials in China, a...
Turin, Italy
Pacifica, California, United States
Santa Monica, United States
Cambridge, United Kingdom
London, United Kingdom
Palo Alto, United States